Gyre Therapeutics (GYRE) Change in Intangibles (2023)
Gyre Therapeutics (GYRE) posted quarterly Change in Intangibles of $1.0 million for Q1 2023.
Gyre Therapeutics (GYRE) Change in Intangibles (2023) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Change in Intangibles for 1 consecutive years, with $1.0 million the latest figure, recorded in Q1 2023.
- In Q1 2023, Change in Intangibles changed N/A year-over-year to $1.0 million; the TTM figure through Sep 2023 stood at $1.0 million (changed N/A YoY), while the FY2022 annual figure was $55.0 million, changed N/A from the prior year.
- Change in Intangibles held at $1.0 million in Q1 2023 per GYRE's latest filing.
- Across five years, Change in Intangibles topped out at $1.0 million in Q1 2023 and bottomed at $1.0 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |